Delayed hyponatraemia(DH) is a common complication following trans-sphenoidal
surgery(TSS) for pituitary tumour. We evaluated the prevalence of DH following
TSS, and assessed the factors associated with DH, including early post-operative
diabetes insipidus(EPDI). This retrospective study included 100 TSS for
pituitary tumours in 98 patients, over a period of 26 months. Subjects were
divided into two groups: those who developed hyponatraemia and those who did not
develop hyponatraemia, during post-operative days 4 to 14. The clinical
characteristics and peri-operative parameters were compared between the two
groups, to identify factors predicting DH. The mean age of the patients was
42.0±13.6 years, 58 (59%) were females and 61 (61%) had
functional tumours. Thirty-six patients(36%) developed DH following TSS
of whom majority(58%) were diagnosed on post-operative days 7 and 8;
only 8/36 (22%) were symptomatic. Syndrome of inappropriate
antidiuretic hormone secretion(SIADH) was found to be the most common aetiology
of DH. On logistic regression analysis, intra-operative cerebrospinal fluid(CSF)
leak (OR 5.0; 95% CI 1.9–13.8; p=0.002), EPDI (OR 3.4;
95% CI 1.3–9.2; p=0.015) and peri-operative steroid use
(OR 3.6; 95% CI 1.3–9.8; p=0.014) were found to be
significantly associated with DH. In conclusion, EPDI, intra-operative CSF leak
and peri-operative steroid use were significant predictors of DH. EPDI predicts
moderate to severe hyponatraemia with 80% specificity but has low
sensitivity(47%). As most patients have asymptomatic hyponatraemia,
serum sodium measurement on POD 7 to 10 would be helpful to identify DH in
patients at increased risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.